Hanmi Pharm Reports Lower Q3 Earnings Despite Higher Sales
Hanmi Pharm reported lower net income despite higher sales in the third quarter of 2026 versus a year earlier.
SEOUL (dpa-AFX) - Hanmi Pharm. Co., Ltd. (128940.KS), a South Korean biopharmaceutical and manufacturing company, on Tuesday reported a decline in net income despite higher sales in the third quarter of 2026 compared with the previous year.For the third quarter, net income attributable to sharehold…